Prayer in Commbate to Corona Virus - Covid -19

Covid19 Clinical Trial

Official title:

A Double Blind, Controlled, Randomized, Prospective Study That Will Evaluate the Impact of Remote Intercession Prayer on the Clinical Evolution of Patients Diagnosed With COVID -19 in HCOR.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04631380
• Other study ID #: PRAYER-COVID19
• Status: Completed
• Phase: N/A
• Start date: August 1, 2020
• Est. completion date: January 1, 2022

Study information

• Verified date: March 2022
• Source: Hospital do Coracao
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.

Description:

PATIENTS WHO AGREE TO PARTICIPATE IN THE STUDY WILL BE SEPARATED INTO 2 GROUPS, THE INTERVENTION GROUP AND THE CONTROL GROUP. THE IDENTITY OF THE PATIENTS WILL BE KEPT IN SECRET AND ONLY THEIR INITIALS WILL BE LISTED. THE INTERVENTION GROUP WILL RECEIVE DAILY PRAYERS AND THE EVOLUTIONARY CLINICAL RESULTS OF THE TWO GROUPS WILL BE PURCHASED.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: January 1, 2022
• Est. primary completion date: June 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Patients hospitalized in comun hospital rooms and intensive care units with confirmed COVID-19.

Exclusion Criteria:

• Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization
• Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection, however, without indication for hospitalization.
• Patients 18 years of age or older
• Patients with indication of palliative care and definition of terminality at hospital admission
• Patients who voluntarily choose not to participate in the study at the time of the • presentation of the Informed Consent Form.

Related Conditions & MeSH terms

• Covid19

Intervention

Other:
• PRAYER
THE PRAYER GROUP WILL RECEIVE ABSOLUTELY THE SAME CARE AS THE CONTROL GROUP PLUS PRAYERS

Locations

Country	Name	City	State
Brazil	Hospital do Coracao	Sao Paulo	SP

Sponsors (1)

Lead Sponsor	Collaborator
Hospital do Coracao

Country where clinical trial is conducted

Brazil, 

References & Publications (5)

Bleich A. [Intercessory prayer for health: a matter of faith, science or both]. Harefuah. 2002 Jun;141(6):522-3. Hebrew. — View Citation

Harris WS, Gowda M, Kolb JW, Strychacz CP, Vacek JL, Jones PG, Forker A, O'Keefe JH, McCallister BD. A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit. Arch Intern Med. 1999 Oct 25;159(19):2273-8. Erratum in: Arch Intern Med 2000 Jun 26;160(12):1878. — View Citation

Hettiaratchy S, Hemsley C. Effect of retroactive intercessory prayer. Paper proves power of statistics, not prayer. BMJ. 2002 Apr 27;324(7344):1037; author reply 1038-9. — View Citation

Hoover DR, Margolick JB. Questions on the design and findings of a randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit. Arch Intern Med. 2000 Jun 26;160(12):1875-6; author reply 1877-8. — View Citation

Radin D, Schlitz M, Baur C. Distant Healing Intention Therapies: An Overview of the Scientific Evidence. Glob Adv Health Med. 2015 Nov;4(Suppl):67-71. doi: 10.7453/gahmj.2015.012.suppl. Epub 2015 Nov 1. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	DEATH OR RECOVERY	WE WILL EVALUATE DEATHS OR HOSPITAL DISCHARGE	60 DAYS
Secondary	NEED FOR MECHANICAL VENTILATION	NEED FOR MECHANICAL VENTILATION	60 DAYS
Secondary	TIME OF REMAINED INTUBATED	TIME OF REMAINED INTUBATED	60 DAYS
Secondary	LENGTH OF STAY IN ICU	LENGTH OF STAY IN ICU	60 DAYS
Secondary	TIME OF STAY HOSPITALIZED	TIME OF STAY HOSPITALIZED	60 DAYS
Secondary	Occurrence of clinical complications.	Occurrence of clinical complications that were not included before diagnostic confirmation and that may be related to covid infection.	60 DAYS